Enovis is a medical technology company that develops orthopedic devices, including bracing, bone-growth stimulation, surgical implants, and reconstructive products for musculoskeletal care.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Howard Marks / Oaktree | 71 | New buy | 39,207,000 | $37,793,587 | 0.5% |
| Bridgewater | 56 | Added +50% | 77,088 | $1,595,722 | 0.0% |
| Ancora | 40 | Trimmed -6% | 337,144 | $6,978,881 | 0.1% |
| Paul Tudor Jones / Tudor | 63 | Trimmed -83% | 25,167 | $520,957 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.